GENPREX (GNPX) vs Alaunos Therapeutics, Inc. (TCRT)

GENPREX and Alaunos Therapeutics, Inc. are both Biotechnology companies. GENPREX and Alaunos Therapeutics, Inc. are of similar size ($2.9M and $2.8M). Alaunos Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; GENPREX trades at 0.0×. Across the 10 metrics below, GENPREX leads on 5 and Alaunos Therapeutics, Inc. on 5.

Valuation

Metric GNPX TCRT Biotechnology median
P/E 0.05 n/m 7.88
P/S n/m 189.35 11.47
P/B 0.11 4.07 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.86 n/m 0.74
EV/Sales n/m 264.13 10.73
Earnings yield 2,033.43% (175.23%) (28.84%)
Free cash flow yield (950.28%) (49.83%) (23.03%)

Profitability

Metric GNPX TCRT Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (203.86%) (185.95%) (57.72%)
Return on assets (157.40%) (128.30%) (49.22%)
Return on invested capital 0.00% (480.35%) 0.00%

Growth

Metric GNPX TCRT Biotechnology median
Revenue growth (TTM) — (17.65%) 5.64%
EPS growth (last fiscal year) 93.48% 24.66% —
Revenue growth, 5-year CAGR — (49.08%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GNPX TCRT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.76 0.77 4.73
Net debt to EBITDA 0.50 0.33 0.96

Dividend

Metric GNPX TCRT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric GNPX TCRT Biotechnology median
Market cap 2.80m 2.87m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack